Composition, possessing tonic and antioxidant action (options)

 

(57) Abstract:

The invention can be used in medicine, food industry. The composition includes dihydroquercetin, ascorbic acid, microcrystalline cellulose, pectin, sorbitol, rosehip extract to dry, the sugar substitute and calcium or magnesium stearate in the following ratio, wt. %: dihydroquercetin 0,5-7,0; MCC 6,0-42,2; ascorbic acid 1-30; pectin 1-15; sorbitol 5-30; rosehip extract dry 50-10; sugar substitute 0,2-1,0; calcium or magnesium stearate 0.1 to 1.0. The composition additionally contains bischofite in the amount of 1-15 weight. %. The composition additionally contains vitamins a and E, each in an amount of 0.1-0,005% and Aerosil in the amount of 0-3%. The invention allows to improve therapeutic and prophylactic properties of the product. 3 S. p. f-crystals.

The invention relates to medicine and food industry, namely the production of vitamin and antioxidant complexes with high biological activity with therapeutic-preventive effect.

Known complex food Supplement with radioprotective action (EN 2077231 C1 20.04.1997).

A comprehensive nutritional Supplement from algae contains laminaria, is as well as it may additionally contain glycine and tocopherol acetate.

Disadvantages: lack of therapeutic efficacy.

The invention is aimed at solving problems: improvement of therapeutic and preventive properties of the composition, the expansion of the range.

These objectives are achieved by the composition "Vitaux" containing bioflavonoids larch, dihydroquercetin, ascorbic acid and, optionally, microcrystalline cellulose (MCC), pectin, sorbitol, rosehip extract to dry, the sugar substitute and calcium or magnesium stearate (option 1).

Composition "Vitax+M" can optionally contain brine Perm sea - bischofite (option 2) and vitamins a, E and Aerosil (option 3) - "Vitax-Forte in the following ratio, wt.%:

Option 1:

Dihydroquercetin - 0,5 - 7,0

ICC - 6,0 - 42,2

Ascorbic acid - 1,0 - 30,0

Pectin - 1,0 - 15,0

Sorbitol - 5,0 - 30,0

Rosehip extract dry - 10,0 - 50,0

The sugar substitute - 0,2 - 1,0

Calcium or magnesium stearate - 0,1 - 1,0

Option 2:

Dihydroquercetin - 0,5 - 7,0

ICC - 5,0 - 27,2

Ascorbic acid - 1,0 - 30,0

Pectin - 1,0 - 15,0

Sorbitol - 5,0 - 30,0

Rosehip extract dry - 10,0 - 50,0

The sugar substitute - 0,2 - 1,0

Calcium or magnesium STA ascorbic - 1,0 - 30,0

Pectin - 1,0 - 15,0

Sorbitol - 5,0 - 30,0

Rosehip extract dry - 10,0 - 50,0

The sugar substitute - 0,2 - 1,0

Calcium or magnesium stearate - 0,1 - 1,0

Bischofite - 1,0 - 15,0

Vitamin a - 0,005 - 0,1

Vitamin E - 0,005 - 0,1

Aerosil - 0 - 3,0

Vitamin composition "Vitaux", "Vitax-M" and "Vitax-Fort" is available in pill form, by mixing the drug and excipients, followed by pelletizing.

Dihydroquercetin has antioxidant properties, capillary protective and anti-inflammatory activity, activates the regeneration of the gastric mucosa, has antioxidant and radioprotective action. Beneficial effect on the state of cardiovascular system, improves blood flow to the heart muscle, reduces blood viscosity and tendency to thrombosis, helps normalize cholesterol in blood, improves eyesight.

Composition, possessing tonic and antioxidant activity Vitaux" (option 1) has a restorative and preventive action, increases efficiency and resistance to infections, prevents the aging process. The composition used for the prevention bronchus is of physical performance and the body's resistance to infections, protect the body from aging.

Way of application and dose: 2 tablets 2 times daily with water, the course of 1 month. Children are encouraged 1/2 adult dose.

Composition, possessing tonic and antioxidant activity Vitaux-M (option 2) has a restorative and preventive action, increases efficiency and resistance to infections, prevents the aging process. The composition used for the prevention of bronchopulmonary diseases, atherosclerosis, coronary heart disease and hypertension, diabetes mellitus, to improve physical performance and the body's resistance to infections, protect the body from aging, prevention of the gastrointestinal tract (gastritis, stomach ulcer).

Way of application and dose: 2 tablets 2 times daily with water, the course of 1 month. Children are encouraged 1/2 adult dose.

Composition, possessing tonic and antioxidant activity Vitaux-Forte" (option 3) has a restorative and preventive action, increases efficiency and resistance to infections, prevents the aging process. The composition used for the prevention of broncho who their physical performance and the body's resistance to infections, protect the body from aging, prevention of diseases of the gastrointestinal tract (gastritis, stomach ulcer).

Way of application and dose: 1 tablet 2 times daily with water, the course of 1 month. Children are encouraged 1/2 adult dose.

Clinical examples.

Example 1.

Zelenin Sasha, 11.

s: dystonia. The syndrome of vegetative-visceral dysfunctions. GIT on hypertonic type. Reactive pancreatitis.

Complaints before treatment: fatigue, weakness, irritability, restless sleep, recurrent headaches, reduced appetite.

The clinic before treatment: Skin is pale, moderate shadows under the eyes, phenomena follicular keratosis. Polyacene. Emotionally labile. Hyperhidrosis of the palms. Heart sounds somewhat muted at the top, the weakening of the first tone, bradyarrhythmia, Ps 64 min, short systolic murmur at the apex, diminished in the orthostasis. Tongue coated from root whitish-gray bloom. The abdomen is soft, moderately painful in so well.p, piloroduodenalnoy area. Liver +0,5 see regular Chair.

These additional studies:

OAK before treatment; radiation - 5,2109/l, (Eg - 4,41012Hb 132 g/l).

Polyreocardiographs study before treatment: - increase in total peripheral resistance - 419, reduced cardiac index - 1,14 (hypokinetic type of circulation), insufficient hydraulic capacity of 0.20.

Received BAD "Vitaux" (option 1 Composition) at a dose of 1 tab. in day. The course of 1 month.

After treatment:

No complaints.

Clinic: Skin is pale, supple, light shadows under the eyes. Improved appetite and sleep. Decreased symptoms of asthenia. There has been improvement in emotional tone, increase physical activity. The rhythmic heart sounds. Tongue slightly furred at the base. The abdomen is soft, painless. Liver at the edge of the costal arch.

OAK after treatment: er. - 4,2, HB - 140, Le - 6,2.

The immunological after treatment: Normalization of T-cell load tests (TGF - 38%, CFC - 11%, thermostable E-ROCK - 30%). The content of Ig A, M, G - normal.

Polyreocardiographs study after treatment will increase the total peripheral resistance, normalization pump function (hydraulic power - 0.90) and energy consumption of the myocardium (81,4).

Vegetative-vascular dystonia. Chronic gastroduodenitis.

Complaints before treatment: fatigue, anxiety, long falls asleep, recurrent abdominal pain, poor appetite.

The clinic before treatment: Skin is pale with a grayish tint, expressed shadows under the eyes, phenomena follicular keratosis. Adenoid type of face. Metropolitane. Distriict. Emotionally labile. Hyperhidrosis of the palms. The mesenchymal deficiency syndrome (waterlilies wrists). Heart sounds slightly muffled, the weakening of the first tone, bradyarrhythmia, Ps 72 min, systolic murmur with hardline shade, the maximum in the fourth intercostal space to the left of the sternum. Tongue coated on the back with white bloom. The abdomen is soft, painless. Liver +2,0 see a chair with a tendency to constipation.

These additional studies:

OAK before treatment: (23.03.99) - Eg - 3,91012Hb 130 g/l), leukopenia 4,9109/l, eosinophilia - 11%, lymphocytopenia - 35%.

Biochemical blood test: (23.03.99), increased cholesterol (5,49) and alkaline phosphatase (656).

The immunological before treatment: the decrease in cellular immunity (null lymphocytes, early E-ROCK, General T-lymphopenia), increase immunoregulatory index. 387, a reduced cardiac index of 1.38 (hypokinetic type of circulation) insufficient hydraulic capacity of 0.23, the energy consumption of the myocardium in normal - 81,4.

Received BAD "Vitaux" (option 1 Composition) at a dose of 1 tab. in day. The course of 1 month.

After treatment:

Complaints: fatigue.

Clinic: Skin is pale, supple, decreased intensity of shadows under the eyes. Decreased symptoms of asthenia. A good appetite, sleep has improved. Became emotionally stable. The rhythmic heart sounds. The language clean. Liver +1,0, see

OAK (24.04.99): Eg - 4,81012, b - 148 g/l, Le - 6,7109/l e - 6%, l - 49%.

Biochemical blood test: (23.03.99) - cholesterol 4,9.

The immunological: (23.06.99) - moderate lymphopenia relative indicators (34%), eosinophilia persists 11%. The tendency to normalization of the act. E-ROCK (27%). The content of Ig A, M, G - normal.

Polyreocardiographs study: 23.04.99 - maintained increase in total peripheral resistance, normalization pump function (hydraulic power - 0.95) and energy consumption of the myocardium (76,1).

Example 3.

Kalinin Lena, age 8.

s: Respiratory allergies. The secondary immunodeficiency syndrome.

The clinic before treatment: Skin is pale, expressed shadows under the eyes, phenomena follicular keratosis Palpable submandibular l/y. Heart sounds somewhat muffled, rhythmic, bradycardia heart rate 64 minutes Language more lined at base whitish bloom. The abdomen is soft, painless. Liver at the edge of the costal arch. A chair with a tendency to constipation.

These additional studies:

OAK before treatment: Eg - 4,31012, b - 127 g/l, Le - 5,8109/l eosin. - 5%, limp. - 42%.

The immunological before treatment: Radiation - 5,9, eosinophilia - 7%, lymphocytosis - 55%, reduced zero-lymphocytes - 18%, reduced Ig A - 0,51.

Polyreocardiographs study before treatment: hypokinetic type of circulation alone (cardiac index was 1.43), moderate increase in total peripheral resistance - 397.

Received BAD "Vitaux" (option 1 Composition) at a dose of 1 tab. in day. The course of 1 month.

After treatment:

No complaints.

Clinic: Skin is pale, supple, decreased intensity of shadows under the eyes. Appetite election, sleep is not disturbed. Heart sounds sonorous, rhythmic. The language clean. The liver is not enlarged.

OAK after treatment: Eg - 4,31012, b - 140 g/l, Le - 5,5109/l, e - 2%.

Polyreocardiographs study after treatment: Akineticheskie type circulation. The level of posterski on the myocardium (total peripheral resistance) corresponds to the norm.

Example 4.

Kozik Violetta, 5 years.

s: Respiratory allergies, dermato-respiratory syndrome (atopic dermatitis, subramania, year-round allergic rhinosinusitis, hidden obstructive syndrome). Secondary immunodeficiency. Dystonia, residual organic Genesis, neurosis-like state, enuresis. Dysbacteriosis of the intestine.

Complaints before treatment: frequent colds, anxiety, poor appetite, recurrent skin rashes.

The clinic before treatment: Skin is pale, expressed shadows under the eyes, phenomena follicular keratosis. Marked dryness, mild redness and peeling cheeks, dry the back of the thighs, legs - plaque dryness, roughness, redness. In the corner of his mouth eating. Polyacene. Asthenic physique. Emotionally labile. Nasal breathing somewhat troubled, sniffs his nose. Vesicular breathing in lungs, a single wired wheezing. Heart sounds somewhat muffled, rhythmic. Tongue coated on the back>These additional studies:

OAK before treatment: Eg - 4,11012Hb - 108 g/l), leukopenia 4,2109/l

Biochemical blood test: - raising ACT (38).

The immunological before treatment: (18.03.99) - improved: T-limp. General (64%), T-TFF. (51%), T-thermostable E-ROCK (60%), reduced T-TFC. (9%), phagocytosis 60%, reduced Ig And (0,87), increased levels of Ig G (14.24 from).

ECG before treatment: (17.03.99) Sinus rhythm, normal position of the electrical axis of the heart, indirect signs of left ventricular hypertrophy.

Polyreocardiographs study before treatment: 13.03.99 - a sharp increase in total peripheral resistance - 962, reduced cardiac index was 0.77 (hypokinetic type of circulation), insufficient hydraulic capacity of 0.08, an increase of power consumption of the myocardium - 78,0, preservation of contractile and pump function.

Received BAD "Vitaux" (option 1 Composition) at a dose of 1/2 tablet. in day. The course of 1 month.

After treatment:

Complaints against anxiety.

Clinic: Skin is pale, supple, decreased intensity of shadows under the eyes, on the cheeks remains easy peeling, feet went plaque dryness, roughness. Decreased symptoms of asthenia. A good appetite. Emotionally the sonority, rhythmic. The language clean. Liver +0.5 cm Chair regular feature.

OAK after treatment (08.04.99): Eg - 4,01012, b - 121 g/l, Le - 6,0109/l

Biochemical blood test: no abnormalities.

The immunological after treatment: (07.04.99) - the tendency to normalization: T-TFF. (48%), T-thermostable E-ROCK (49%). Remains increased activity of phagocytosis (65%), level of Ig G (17,49) and Ig M (2,89). Normalization of contents Ig A (1,33).

ECG after treatment: (05.04.99) Sinus rhythm, normal position of the electrical axis of the heart, indirect signs of left ventricular hypertrophy.

Polyreocardiographs study: 18.04.99 - Akineticheskie type circulation. Saved the increase in total peripheral resistance. Normalization pump function (hydraulic power - 0,82) and energy consumption of the myocardium (76,0).

Example 5.

Zaykov Nikita 12 years.

s: dystonia, astheno-neurotic syndrome. Cephalgia voltage. Chronic gastroduodenitis. GIT.

Secondary immunodeficiency.

Complaints before treatment: headaches, fatigue, weakness, irritability, restless sleep, recurrent abdominal pain, decreased the of retosa. Palpable submandibular l/y. Gnm II degree. Emotionally labile. Heart sounds somewhat muted on the top, short systolic murmur along the left edge of the sternum, Ps 84 minutes Language coated on the back whitish-gray bloom. The abdomen is soft, slightly painful in the right hypochondrium, T. J. p. Liver at the edge of the costal arch. Chair regular.

These additional studies:

OAK before treatment: Eg - 4,31012Hb 138 g/l, Le - 6,8109/l, limp. - 22%.

The immunological before treatment: lymphopenia 23%, increase T-TFF. 57%, a sharp decline in T-TFC. 1%, reduced phagocytic index of 1.13, the level of Ig M - 0,84.

Polyreocardiographs study before treatment: - moderate increase in total peripheral resistance - 419, hypokinetic type of circulation (reduced cardiac index was 1.04), moderate increase in power consumption of the myocardium (double work - 76,9).

Received BAD "Vitaux" (option 1 Composition) at a dose of 1 tab. in day. The course of 1 month.

After treatment:

Complaints of recurrent headaches after exercise.

Clinic: Skin physiological color, elastic, light shadows under the eyes. Improved appetite, sleep calm. Improving emotional what about the syndrome. The rhythmic heart sounds. Tongue slightly furred at the base. The abdomen is soft, painless. Liver at the edge of the costal arch.

OAK: Eg - 4,3l012/l, Hb - 146 g/l, Le - 6,3109/l, limp. - 37%.

The immunological after treatment: - the content of lymphocytes in normal 29%, and Normalization of T-TFF - 42% and T-TFC - 8% with some decrease thermostable E-ROCK - 15%, remains reduced phagocytic link (phagocytosis 21%, phagocytic number - 0 28, phagocytic index of 1.34). Normalization level Ig M - 1,13, the content of Ig And (2,28) and Ig G (14,27) - normal.

Polyreocardiographs study will increase the total peripheral resistance, normalization pump function (hydraulic power - to 0.94) and power consumption of the myocardium (82).

Example 6.

Elders Timothy, 14 years.

Ds: Borderline hypertension.

Heredity: the mother Arterial hypertension (GB II century).

The clinic before treatment:

Complaints of frequent headaches, stabbing pain in the heart after emotional stress, fatigue, irritability, recurrent nosebleeds, "numbness" of the fingers, restless sleep. The General condition is satisfactory. the rhythmic.

OAK: er - 4,51012/l b - 147 g/l, Col. p. 34 PG. Tr-you 220109/l L 4,9109/l, e 2, P 1, p 63, L 30, M 4, erythrocyte sedimentation rate of 7 mm/h

ECG: Sinus arrhythmia. Dysmetabolic changes in the myocardium of the ventricles. SRRI.

GOKR: Hyperkinetic type blood alone.

Hemodynamic parameters:

OPS -

GM (

DP -

CH. bottom: the optic nerve disc pale pink. Artery is tortuous, constricted. Vienna full. Signs of a vascular dystonia.

Received treatment: "Vitax-M (option 1 Composition) at a dose of 1 tab. 2 times a day for 1 month.

Clinic after treatment:

Complaints: does not show. Being significantly improved. Headaches do not bother. Disappeared "numbness in the fingers. The General condition is satisfactory. Skin pale, shadows under his eyes disappeared. HELL 120/80 mm RT.art., HR 82 in minutes heart sounds sonorous, rhythmic.

UAC: er - 4,11012/l, Hb 127 g/l, Col. p. 30 PG, Tr-you 200109/l L 5,4109/l e 1, P 2, p 62, L 30, M 5, ESR 8 mm/h

ECG: Sinus rhythm. SRRI.

GOKR: Hyperkinetic type blood alone.

Hemodynamic parameters:

OPS - 154 (N)

GM - 1,1 (N)

PD - 102 (N)

CH. bottom: pink optic nerve disc. Artery is tortuous, the usual diameter is.

Ds: dystonia residual organic Genesis on vagotomies type. False angina. Cephalgia. Permanent course.

Heredity: the father - Arterial hypertension (GB II century),

mother - vascular dystonia on sympathicotonia type.

The clinic before treatment:

Complaints expressed headaches, dizziness, increased sweating (especially at night), pain in the heart after emotional stress, fatigue, irritability, recurrent nosebleeds, pain in the extremities and "numbness" of the fingers. The General condition is satisfactory. Pale skin, shadows around the eyes. Expressed General hyperhidrosis. HELL 90/60, HR 64 in minutes heart sounds moderately evenly reduces the tendency to bradyarrhythmia.

OAK: er - 4,31012/l b 146 g/l, Col. p. 34 PG, Tr-you 200109/l L 5,7109/l, e 2, P 2, p 63, L 29, M 4, erythrocyte sedimentation rate of 3 mm/h

ECG: Sinus bradyarrhythmia. Episodes migration of the pacemaker in the Atria. SRRI.

GOKR: Hypokinetic type of circulation alone.

Hemodynamic parameters:

OPS - 145 (N)

GM

APS - 96 (N)

CH. bottom: the optic nerve disc pale pink. The tortuous artery, normal diameter. is and at a dose of 1/2 table. 1 time a day for 1 month.

Clinic after treatment:

Complaints: does not show. Being significantly improved. Sweating has decreased. Headaches do not bother. No pain in the extremities and numbness in the fingers. The General condition is satisfactory. Skin pale, shadows under his eyes disappeared. HELL 100/70 mm RT. senior HR 72 in minutes heart sounds loud, moderately irregular.

OAK: er - 4,11012/l b 126 g/l, Col. p. 30 PG, Tr-you 200109/l L 6,4109/l, e 2, P 2, p 61, L-31, M-4, erythrocyte sedimentation rate 5 mm/h

ECG: Sinus rhythm. SRRI.

GOKR: Hypokinetic type of circulation alone.

Hemodynamic parameters:

OPS - 145 (N)

GM - 1,2 (N)

APS - 96 (N)

CH. bottom: pink optic nerve disc. The tortuous artery, normal diameter. Vienna is not changed. Signs of vascular dystonia no.

Example 8.

Corner Valera, 14 years.

Ds: dystonia residual organic origin on the mixed type. The syndrome of hypertension. Paroxysmal over.

Heredity: the father of Arterial hypertension.

The clinic before treatment:

Complaints of recurrent headaches, stabbing pain in the heart after a multi-sensory shower the roses palms. The General condition is satisfactory. Pale skin. Extremities cold to the touch. HELL 130/85, heart rate 78 in minutes heart sounds moderately reduces the tendency to bradyarrhythmia.

OAK: er - 4,51012/l b 142 g/l, Col. p. 31,5 PG, Tr-you 210109/l L 6,5109/l e 1, P 4, p 70, L 21, M 4, ESR 8 mm/h

ECG: Sinus arrhythmia, bradyarrhythmia. SRRI.

GOKR Hypokinetic type of circulation alone.

Hemodynamic parameters:

OPS -

GM

DP -

CH. bottom: the optic nerve disc pale pink border along the vascular bundle stosowana. Artery is tortuous, constricted. Vienna moderately full. Signs of a vascular dystonia.

Received treatment: "Vitax-M (option 2 Songs) at a dose of 1/2 table. 2 times a day for 1 month.

Clinic after treatment:

Complaints: does not show. Being significantly improved. Headaches do not bother. Disappeared "numbness in the fingers. The General condition is satisfactory. Skin pale, shadows under his eyes disappeared. HELL 120/70 mm RT. senior HR 78 in minutes heart sounds sonorous, rhythmic.

OAK: er - 4,21012/l b 130 g/L. CV. p. 30 PG, Tr-you 200109/l L 6,5109/l e 1, P 4, p 63, L 28, M 4, erythrocyte sedimentation rate 5 mm/h

ECG: Sinus rhythm. Normal e/BR> OPS - 144 (N)

GM - 1,1 (N)

PD - 106 (N)

CH. bottom: the optic nerve disc pink tortuous Artery, normal diameter. Vienna is not changed. Signs of vascular dystonia no.

Example 9.

Kaverin Dmitry, 9 years old.

Ds: dystonia residual organic origin on the mixed type. Paroxysmal over.

Heredity: the mother Arterial hypertension. (GB Art. I).

The clinic before treatment:

Complaints of recurrent headaches, stabbing pain in the heart after emotional stress, fatigue, irritability, numbness of the fingers of the hands, restless sleep, hyperhidrosis of the palms. The General condition is satisfactory. Pale skin. Extremities cold to the touch. HELL 120/80, HR 68 in minutes heart sounds moderately reduces the tendency to bradyarrhythmia.

OAK: er - 4,31012/l b 140 g/l, Col. p. 31 PG, Tr-you 200109/l L 6,1109/l e 1, P 4, p 68, L 23, M 4, erythrocyte sedimentation rate of 11 mm/h

ECG: Sinus arrhythmia, bradyarrhythmia. SRI. Dysmetabolic changes in the myocardium of the ventricles.

GOKR: Hypokinetic type of circulation alone.

Hemodynamic parameters:

OPS -

GM

DP -

CH. bottom: the optic nerve disc pale pink, gr is stand dystonia.

Received treatment: "Vitax-Forte" (option 3 Songs) at a dose of 1/2 table. 2 times a day for 1 month.

Clinic after treatment:

Complaints: does not show. Being significantly improved. Headaches do not bother. Disappeared "numbness in the fingers. The General condition is satisfactory. Skin pale, shadows under his eyes disappeared. HELL 110/70 mm RT. senior HR 78 in minutes heart sounds sonorous, rhythmic.

OAK: er - 4,21012/l b 130 g/l, Col. p. 30 PG, Tr-you 200109/l L 6,5109/l, e 2, P 3, p 61, L 30, M 4, erythrocyte sedimentation rate of 7 mm/h

ECG: Sinus rhythm. Normal El. the axle.

GOKR: Hypokinetic type of circulation alone.

Hemodynamic parameters:

OPS - 124 (N)

GM - 0,9 (N)

DP - 98 (N)

CH. bottom: pink optic nerve disc. The tortuous artery, normal diameter. Vienna is not changed. Signs of vascular dystonia no.

Example 10.

Busarev Alexander, 13 years old.

Ds: Borderline hypertension.

Heredity: the mother Arterial hypertension,

father Arterial hypertension (GB II century).

The clinic before treatment:

Complaints of frequent headaches after emotional stress, fatigue, irritability, edno, shadows around the eyes. Extremities cold to the touch. HELL 135/80, 96 HR in minutes heart sounds clear, rhythmic.

OAK: er - 4,51012/l b 129 g/l, Col. p. 30 PG, Tr-you 220109/l L 4,9109/l e 1, P 4, p 39, L 49, M 7, erythrocyte sedimentation rate of 7 mm/h

ECG: Sinus arrhythmia. Dysmetabolic changes in the myocardium of the ventricles. SRRI.

GOKR: Hyperkinetic type blood alone.

Hemodynamic parameters:

OPS -

GM

DP -

CH. bottom: the optic nerve disc pale pink. Artery is tortuous, constricted. Vienna full. Signs of a vascular dystonia.

Received treatment: "Vitax-Forte" (option 3 Songs) at a dose of 1 tab. 2 times a day for 1 month.

Clinic after treatment:

Complaints: does not show. Being significantly improved. Headaches do not bother. Disappeared "numbness in the fingers. The General condition is satisfactory. Skin pale, shadows under his eyes disappeared. HELL 120/80 mm RT. senior HR 78 in minutes heart sounds sonorous, rhythmic.

OAK: er - 4,11012/l b 127 g/l, Col. p. 30 PG, Tr-you 210109/l L 5,4109/l e 1, P 2, p 59, L 33, M 5, erythrocyte sedimentation rate 5 mm/h

ECG: Sinus rhythm. SRRI.

GOKR: Hyperkinetic type blood alone.

Parameters hemodi the and. Vienna is not changed. Signs of vascular dystonia no.

Example 11.

Kuminov Tatiana, 7 years.

Ds: dystonia residual organic Genesis on vagotomies type. Cephalgia. Permanent course.

Heredity: the mother Arterial hypertension (GB II century).

The clinic before treatment:

Complaints expressed headaches, dizziness, increased sweating (especially at night) after emotional stress, fatigue, irritability, recurrent nosebleeds, "numbness" of the fingers. The General condition is satisfactory. Pale skin, shadows around the eyes. Expressed General hyperhidrosis. HELL 90/50, pulse rate 96 in minutes heart sounds moderately evenly muted, arrhythmic.

OAK: er - 4,41012/l b 133 g/l, Col. p. 30 PG, Tr-you 210109/l L 8,6109/l e 3, Paragraph 5, 52, L 35, M 5, erythrocyte sedimentation rate 5 mm/h

ECG: Sinus arrhythmia. Dysmetabolic changes in the myocardium of the ventricles.

GOKR: Hypokinetic type of circulation alone.

Hemodynamic parameters:

OPS - 140 (N)

GM

DP - 91 (N)

CH. bottom: the optic nerve disc pale pink. The tortuous artery, normal diameter. Vienna full. Signs canopy within 1 month.

Clinic after treatment:

Complaints: does not show. Being significantly improved. Sweating has decreased. Headaches do not bother. Disappeared "numbness in the fingers. The General condition is satisfactory. Skin pale, shadows under his eyes disappeared. HELL 90/6O mm RT. senior HR 92 min heart sounds loud, moderately irregular.

OAK: er - 4,21012/l b 128 g/l, Col. p. 30 PG, Tr-you 200109/l L 5,4109/l, e 2, P 2, p 62, L 30, M 4, ESR 8 mm/h

ECG: Sinus rhythm.

GOKR: Hypokinetic type of circulation alone.

Hemodynamic parameters:

OPS - 145 (N)

GM - 1,0 (N)

DP - 98 (N)

CH. bottom: pink optic nerve disc. Artery is tortuous, the normal diameter of the vein is not changed. Signs of vascular dystonia no.

Examples related to the composition.

Example 1.

Dihydroquercetin - 0,5

ICC - 42,2

Ascorbic acid - 1,0

Pectin - 1,0

Sorbitol - 5,0

Rosehip extract dry - 50,0

The sugar substitute - 0,2

Calcium or magnesium stearate, and 0.1

Example 2.

Dihydroquercetin - 7,0

ICC - 6,0

Ascorbic acid - 30,0

Pectin - 15,0

Sorbitol - 30,0

Rosehip extract dry - 10,0

Substitute charismata ascorbic - 1,0

Pectin - 1,0

Sorbitol - 5,0

Rosehip extract dry - 50,0

The sugar substitute - 0,2

Calcium or magnesium stearate, and 0.1

Bischofite - 15,0

Example 4.

Dihydroquercetin - 7,0

ICC - 5,0

Ascorbic acid - 30,0

Pectin - 15,0

Sorbitol - 30,0

Rosehip extract dry - 10,0

The sugar substitute - 1,0

Calcium or magnesium stearate - 1,0

Bischofite - 1,0

Example 5.

Dihydroquercetin - 0,5

ICC - 24,0

Ascorbic acid - 1,0

Pectin - 1,0

Sorbitol - 5,0

Rosehip extract dry - 50,0

The sugar substitute - 0,2

Calcium or magnesium stearate, and 0.1

Bischofite - 15,0

Vitamin a - 0,1

Vitamin E - A 0.1

Aerosil - 3,0

Example 6.

Dihydroquercetin - 7,0

ICC - 4,99

Ascorbic acid - 30,0

Pectin - 15,0

Sorbitol - 30,0

Rosehip extract dry - 10,0

The sugar substitute - 1,0

Calcium or magnesium stearate - 1,0

Bischofite - 1,0

Vitamin a - 0,005

Vitamin E - 0,005

Aerosil - 0,0-

1. The composition having a tonic and antioxidant containing bioflavonoids and vitamins, characterized in that it contains bioflavonoids dihydroquercetin, rosehip extract to dry, the sugar substitute and calcium or magnesium stearate in the following ratios, wt%:

Dihydroquercetin - 0,5 - 7,0

ICC - 6,0 - 42,2

Ascorbic acid - 1,0 - 30,0

Pectin - 1,0 - 15,0

Sorbitol - 5,0 - 30,0

Rosehip extract dry - 10,0 - 50,0

The sugar substitute - 0,2 - 1,0

Calcium or magnesium stearate - 0,1 - 1,0

2. Composition, possessing tonic and antioxidant containing bioflavonoids and vitamins, characterized in that it contains bioflavonoids dihydroquercetin as vitamins - ascorbic acid, and optionally, bischofite, microcrystalline cellulose, pectin, sorbitol, rosehip extract to dry, the sugar substitute and calcium or magnesium stearate in the following ratios, wt%:

Dihydroquercetin - 0,5 - 7,0

ICC - 5,0 - 27,2

Ascorbic acid - 1,0 - 30,0

Pectin - 1,0 - 15,0

Sorbitol - 5,0 - 30,0

Rosehip extract dry - 10,0 - 50,0

The sugar substitute - 0,2 - 1,0

Calcium or magnesium stearate - 0,1 - 1,0

Bischofite - 1,0 - 15,0

3. Composition, possessing tonic and antioxidant containing bioflavonoids and vitamins, characterized in that it contains bioflavonoids dihydroquercetin, as the vitamin is it rosehip extract to dry, the sugar substitute and calcium or magnesium stearate in the following ratios, wt%:

Dihydroquercetin - 0,5 - 7,0

ICC - 4,99 - 24,0

Ascorbic acid - 1,0 - 30,0

Pectin - 1,0 - 15,0

Sorbitol - 5,0 - 30,0

Rosehip extract dry - 10,0 - 50,0

The sugar substitute - 0,2 - 1,0

Calcium or magnesium stearate - 0,1 - 1,0

Bischofite - 1,0 - 15,0

Vitamin a - 0,005 - 0,1

Vitamin E - 0,005 - 0,1

Aerosil - 0 - 3,0 n

 

Same patents:

The invention relates to the field of veterinary medicine

The invention relates to medicine, in particular to otolaryngology

The invention relates to medicine, specifically to preventive pharmacology, and relates to means for improving mental and physical performance both healthy and sick people

The invention relates to medicine, namely to drugs and medicines for the treatment and prevention of diseases of internal organs, particularly the liver, as well as the treatment of toxicosis of different etiology

The invention relates to veterinary pharmacology, obstetrics and gynecology

Immunomodulator // 2185848
The invention relates to medicine, namely to treatment-and-prophylactic means of plant origin, and can be used as immunomodulator

The invention relates to medicine, in particular to the means possessing sedative effect
The invention relates to medicine, namely to plant charges, which can be used in the treatment of diseases of the gastrointestinal tract

The invention relates to pharmaceutical industry

The invention relates to pharmaceutical industry

The invention relates to medicine, neonatology, and to methods of correction of Central hemodynamics in newborn
The invention relates to the field of medicine

The invention relates to the technology of inorganic materials used in dentistry
The invention relates to medicine and can be used for treatment of burns

The invention relates to medicine, specifically to medicines for the treatment of prostatitis and BPH
The invention relates to medicine and can be used in neurosurgery and neurotraumatology and surgery to stop capillary bleeding

The invention relates to medicine and relates to a means for relief of alcohol withdrawal syndrome
The invention relates to medicine and can be used in therapy, for immunocorrective
The invention relates to the field of animal husbandry

The invention relates to pharmaceutical industry
Up!